Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 51, 2013, Pages 20747-20752

  Skurnik, David ^a   Roux, Damien ^a   Cattoir, Vincent ^b,c   Danilchanka, Olga ^b   Lu, Xi ^a   Yoder Himes, Deborah R ^d   Han, Kook ^b   Guillard, Thomas ^a   Jiang, Deming ^a   Gaultier, Charlotte ^a   Guerin, François ^c   Aschard, Hugues ^e   Leclercq, Roland ^c   Mekalanos, John J ^b   Lory, Stephen ^b   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITÉ DE CAEN   (France)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBAPENEM; DRINKING WATER; GENTAMICIN; OPRD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOTOXICITY; GENE INSERTION; GENE INSERTION SEQUENCE; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; IN VIVO STUDY; INTESTINE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; MOUSE; MUTANT; NEUTROPENIA; NONHUMAN; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RNA SEQUENCE; ROOM TEMPERATURE; SPLEEN; TRANSPOSON; TWITCHING MOTILITY;

EID: 84890817835     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1221552110     Document Type: Article

References (30)

1. Kaki R, et al. (2011) Impact of antimicrobial stewardship in critical care: A systematic review. J Antimicrob Chemother 66(6):1223-1230.
2. Sabuncu E, et al. (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 6(6):e1000084.
3. Levin BR (2001) Minimizing potential resistance: A population dynamics view. Clin Infect Dis 33(Suppl 3):S161-S169.
4. Andersson DI (2006) The biological cost of mutational antibiotic resistance: Any practical conclusions Curr Opin Microbiol 9(5):461-465.
5. Randall LP, et al. (2008) Fitness and dissemination of disinfectant-Selected multipleantibiotic-Resistant (MAR) strains of Salmonella enterica serovar Typhimurium in chickens. J Antimicrob Chemother 61(1):156-162.
6. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: Is it possible to reverse resistance Nat Rev Microbiol 8(4):260-271.
7. Folkesson A, et al. (2012) Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: An evolutionary perspective. Nat Rev Microbiol 10(12):841-851.
8. Goodman AL, et al. (2009) Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6(3):279-289.
9. Skurnik D, et al. (2013) A comprehensive analysis of in vitro and in vivo genetic fitness of pseudomonas aeruginosa using high-Throughput sequencing of transposon libraries. PLoS Pathog 9(9):e1003582.
10. Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ (2013) Identification of T6SS-Dependent effector and immunity proteins by Tn-Seq in Vibrio cholerae. Proc Natl Acad Sci USA 110(7):2623-2628.
11. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ (2009) Tracking insertion mutants within libraries by deep sequencing and a genome-Wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci USA 106(38): 16422-16427.
12. Tancrède CH, Andremont AO (1985) Bacterial translocation and gram-Negative bacteremia in patients with hematological malignancies. J Infect Dis 152(1):99-103.
13. Lee DG, et al. (2006) Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7(10):R90.
14. Koh AY, Priebe GP, Pier GB (2005) Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect Immun 73(4):2262-2272.
15. Burrows LL (2012) Pseudomonas aeruginosa twitching motility: Type IV pili in action. Annu Rev Microbiol 66:493-520.
16. Kal AJ, et al. (1999) Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell 10(6):1859-1872.
17. Montor WR, et al. (2009) Genome-Wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-Assembling protein microarrays. Infect Immun 77(11):4877-4886.
18. Winsor GL, et al. (2011) Pseudomonas Genome Database: Improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res 39(Database issue):D596-D600.
19. Liberati NT, et al. (2006) An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci USA 103(8): 2833-2838.
20. Tenover FC, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-Field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 33(9):2233-2239.
21. Mishra M, et al. (2012) Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-Mediated opsonization. Cell Microbiol 14(1):95-106.
22. McConnell EL, Basit AW, Murdan S (2008) Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-Vivo experiments. J Pharm Pharmacol 60(1):63-70.
23. Cattoir V, et al. (2013) Transcriptional response of mucoid pseudomonas aeruginosa to human respiratory mucus. mBio 3(6): E00410-E00412.
24. Peña C, et al.; Spanish Network for Research in Infectious Diseases REIPI (2012) Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 56(3):1265-1272.
25. Ocampo-Sosa AA, et al. (2012) Alterations of oprd in carbapenem- Intermediate and-Susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob Agents Chemother 56(4): 1703-1713.
26. Cabot G, et al.; Spanish Network for Research in Infectious Diseases (REIPI) (2012) Genetic markers of widespread extensively drug-Resistant Pseudomonas aeruginosa high-Risk clones. Antimicrob Agents Chemother 56(12):6349-6357.
27. Hocquet D, et al. (2007) Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 51(10):3531-3536.
28. Wolter DJ, et al. (2008) Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Clin Infect Dis 46(12):e137-E141.
29. Eren E, et al. (2012) Substrate specificity within a family of outer membrane carboxylate channels. PLoS Biol 10(1):e1001242.
30. Pirnay JP, et al. (2009) Pseudomonas aeruginosa population structure revisited. PLoS ONE 4(11):e7740.